alovudine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeraj, R; Liu, G; McNeel, DG; Perlman, S; Scarpelli, M; Zahm, C | 1 |
1 trial(s) available for alovudine and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Dideoxynucleosides; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Vaccines, DNA | 2019 |